Pulmonary arterial hypertension (PAH) is an important cause of morbidity and mortality in children. In this Review, Latus et al. describe the latest medical, interventional, and surgical approaches to treating paediatric PAH. The authors highlight new PAH-specific drugs that are in development, and combined hybrid procedures that are delaying the need for lung transplantation.
- Heiner Latus
- Tammo Delhaas
- Christian Apitz
